Clinical Trial Update: Safety and Tolerability Study of Allogeneic Mesenchymal Stem Cell Infusion in Adults With Cystic Fibrosis [Phase 1]

View source ↗

Summary

Phase 1 safety and tolerability study of allogeneic mesenchymal stem cell infusion in adults with cystic fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Allogeneic mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Cystic Fibrosis | Phase 1 | Status: COMPLETED | Results posted: 2023-01-30